Publikationer 2019

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.
Ann Rheum Dis. 2019 Nov;78(11):1536-1544. doi: 10.1136/annrheumdis-2019-215427.

Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study. 
Ilar A, Klareskog L, Saevarsdottir S, Wiebert P, Askling J, Gustavsson P, Alfredsson L.
RMD Open. 2019 Jul 11;5(2):e000978. doi: 10.1136/rmdopen-2019-000978. eCollection 2019.

Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice.
Lindström U, Olofsson T, Wedrén S, Qirjazo I, Askling J.
Arthritis Res Ther. 2019 May 28;21(1):128. doi: 10.1186/s13075-019-1908-9.

Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.
Westerlind H, Holmqvist M, Ljung L, Frisell T, Askling J.
Ann Rheum Dis. 2019 May;78(5):683-687. doi: 10.1136/annrheumdis-2018-214828. Epub 2019 Feb 20.

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register.
Frisell T, Dehlin M, Di Giuseppe D, Feltelius N, Turesson C, Askling J; ARTIS Study Group .
Rheumatology (Oxford). 2019 Jan 21. doi: 10.1093/rheumatology/key433. [Epub ahead of print]

Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
Grøn KL, Arkema EV, Glintborg B, Mehnert F, Østergaard M, Dreyer L, Nørgaard M, Krogh NS, Askling J, Hetland ML; ARTIS Study Group.
Ann Rheum Dis. 2019 Mar;78(3):320-327. doi: 10.1136/annrheumdis-2018-214326. Epub 2019 Jan 5.

Machine-learning based knowledge discovery in rheumatoid arthritis related registry data to identify predictors of persistent pain.
Lötsch J, Alfredsson L, Lampa J.
Pain. 2019 Aug 30. doi: 10.1097/j.pain.0000000000001693. [Epub ahead of print]

Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden.
Einarsson JT, Willim M, Saxne T, Geborek P, Kapetanovic MC.
Rheumatology(Oxford). 2019 Jul 13. pii: kez273. doi: 10.1093/rheumatology/kez273. [Epub ahead of print]

Comparison of agreement between internet-based registration of patient-reported outcomes and clinic-based paper forms within the Swedish Rheumatology Quality Register.
Hofstedt O, Di Giuseppe D, Alenius GM, Stattin N, Forsblad-D’Elia H, Ljung L.
Scand J Rheumatol. 2019 Jul;48(4):326-330. doi: 10.1080/03009742.2018.1551964. Epub 2019 Feb 13.

Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study.
Leclair V, Galindo-Feria AS, Dastmalchi M, Holmqvist M, Lundberg IE.
Rheumatology(Oxford). 2019 Jul 1;58(7):1214-1220. doi: 10.1093/rheumatology/key450.

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden.
Einarsson JT, Willim M, Ernestam S, Saxne T, Geborek P, Kapetanovic MC.
Rheumatology(Oxford). 2019 Feb 1;58(2):227-236. doi: 10.1093/rheumatology/key054.